In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 5, 1999, Pages 1298-1300

  Akova, Murat ^a   Gür, Deniz ^a   Livermore, David M ^a,b   Kocagöz, Tanil ^a   Akalin, H Erdal ^a,c  

^a HACETTEPE UNIVERSITY   (Turkey)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; OFLOXACIN; QUINOLONE; RIFAMPICIN; STREPTOMYCIN;

ACIDITY; ALKALINITY; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BRUCELLA MELITENSIS; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; NONHUMAN; PH; PRIORITY JOURNAL;

EID: 0345517292     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.5.1298     Document Type: Article

References (13)

1. Akalin, H., S. Ünal, D. Gür, and M. Baykal. 1990. Ofloxacin in the treatment of brucellosis. Eur. J. Clin. Microbiol. Infect. Dis. 1990:325-328. (Special issue: Proceedings of the Third International Symposium on Quinolones, Vancouver, Canada, 1990.)
2. Akova, M., Ö. Uzun, H. E. Akalin, M. Hayran, S. Ünal, and D. Gür. 1993. Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin. Antimicrob. Agents Chemother. 37:1831-1834.
3. Al-Sibai, M. B., M. A. Halim, M. M. El-Shaker, B. A. Khan, and S. M. H. Quadri. 1992. Efficacy of ciprofloxacin for treatment of Brucella melitensis infections. Antimicrob. Agents Chemother. 36:150-152.
4. Ariza, J., F. Gudiol, R. Pallares, P. F. Viladrich, G. Rufi, J. Corredoira, and M. R. Miravitlles. 1992. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized double-blind study. Ann. Intern. Med. 117:25-30.
5. Chow, A. W., J. Wong, and K. H. Bartlett. 1988. Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophilia. Antimicrob. Agents Chemother. 32:782-784.
6. Domingo, S., I. Gastearena, A. I. Vitas, I. Lopez-Goni, C. Dios-Vleitez, and R. Diaz. 1995. Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice. J. Antimicrob. Chemother. 36:647-656.
7. Garcia-Rodriguez, J. A., J. E. G. Sanchez, and I. Trujillano. 1991. Lack of effective bactericidal activity of new quinolones against Brucella spp. Antimicrob. Agents Chemother. 35:756-759.
8. Kornfeld, S., and I. Mellman. 1989. The biogenesis of lysosomes. Annu. Rev. Cell Biol. 5:483-525.
9. Lang, R., and E. Rubinstein. 1992. Quinolones for the treatment of brucellosis. J. Antimicrob. Chemother. 29:357-363.
10. National Committee for Clinical Laboratory Standards. 1998. Performance standards for antimicrobial susceptibility testing. Eighth informational supplement. NCCLS document M100-S8, vol. 18. National Committee for Clinical Laboratory Standards, Wayne, Pa.
11. Peer, E. J., E. Clavijo, M. C. Negales, and I. G. Garcia Luque. 1988. Interaction of aminoglycosides and cephalosporins against Pseudomonas aeruginosa. Correlation between interaction index and killing curve. J. Antimicrob. Chemother. 22:175-183.
12. Quadri, S. M., M. A. Halim, Y. Ueno, F. M. Abumustafa, and A. G. Postle. 1995. Antibacterial activity of azithromycin against Brucella melitensis. Chemotherapy (Basel) 41:253-256.
13. Young, E. J. 1995. An overview of human brucellosis. Clin. Infect. Dis. 21: 283-290.